Speaker

Dr Eric Reiman, Banner Alzheimer’s Institute, Phoenix, USA

Dr Reiman

Dr Reiman is Executive Director of the Banner Alzheimer’s Institute, Chief Executive Officer of Banner Research, a professor of psychiatry at the University of Arizona, a university professor of neuroscience at Arizona State University, Clinical Director of Neurogenomics at the Translational Genomics Research Institute, and Director of the Arizona Alzheimer’s Consortium. Dr Reiman’s research interests include brain imaging, genomics, the unusually early detection and tracking of Alzheimer’s disease, and the accelerated evaluation of Alzheimer’s prevention therapies. He is also interested in new models of research collaboration and dementia care. He and his Banner Alzheimer’s Institute colleagues lead the Alzheimer’s Prevention Initiative (API), including prevention trials in cognitively unimpaired persons who, based on their genetic background and age, are at high risk for Alzheimer’s disease, biomarker development, data and sample sharing agreements, unusually large registries to support enrollment in prevention trials, and other efforts to help accelerate the evaluation of prevention therapies. Dr Reiman is an author of more than 300 publications, a principal investigator of several NIH grants, and a recipient of the Potamkin Prize.

« Go Back

Supporting Publication
Organised by
 
  • Lancet Neurology
  • Elsevier
Silver Sponsor
 
Teva
Sponsors
 
AstraZeneca